コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 uires dimerization, which is induced by 2'3' cyclic GMP-AMP (cGAMP) produced by the cGAMP synthase in
2 minimize intracellular accumulation of 2'3'-cyclic GMP-AMP (2'3'-cGAMP) to further avoid downstream
4 xhibited increased TB disease, cGAS and 2'3'-cyclic GMP-AMP (cGAMP) expression, and type I IFN produc
5 cyclic GMP-AMP synthase, which produces 2'3'-cyclic GMP-AMP (cGAMP) that binds to and activates stimu
6 verse physiological contexts, including 2'3'-cyclic GMP-AMP (cGAMP) transport and downstream stimulat
7 Ab and TH responses than the mammalian 2'3'-cyclic GMP-AMP (cGAMP), and generated better protection
8 through binding the cyclic dinucleotide 2'3'-cyclic GMP-AMP (cGAMP), produced by the DNA sensor cycli
9 with low nanomolar activity to inhibit 2'3'-cyclic GMP-AMP (cGAMP)-induced STING activation and rele
10 e immune cyclic GMP-AMP synthase (cGAS)-2'3'-cyclic GMP-AMP (cGAMP)-stimulator of interferon genes (S
11 A, cGAS generates the second messenger 2',3'-cyclic GMP-AMP (cGAMP) that directly binds to and activa
13 izes the dinucleotide second messenger 2',3'-cyclic GMP-AMP (cGAMP), which binds to the endoplasmic r
14 lso required for the inhibition of the 2',3'-cyclic GMP-AMP (cGAMP)-dependent immune responses during
16 stal structures of Acb1 in complex with 3'3'-cyclic GMP-AMP define a mechanism of metal-independent h
20 d metastasis by dampening extracellular 2'3'-cyclic-GMP-AMP (cGAMP)-STING-mediated antitumoral immuni
21 n contrast to the natural STING ligand 2',3'-cyclic-GMP-AMP (cGAMP), PC7A stimulates the prolonged pr
23 validation also revealed the activation of a cyclic GMP-AMP synthase (cGAS)-dependent type I interfer
24 that is responsible for the activation of a cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
26 endogenous DNA substrate of TREX1 triggers a cyclic GMP-AMP synthase-dependent type I IFN response an
28 l DNA release into the cytosol and activated cyclic GMP-AMP Synthase-Stimulator of interferon genes (
30 ytosolic mitochondrial DNA (mtDNA) activates cyclic GMP-AMP synthase-stimulator of interferon genes (
31 1 (ENPP1), which hydrolyzes STING-activating cyclic GMP-AMP (cGAMP), is a safer and more effective ST
32 ble to bind c-di-AMP and with lower affinity cyclic GMP-AMP (3'3'-cGAMP) but not c-di-GMP or 2'3'-cGA
33 particles (MPs) to deliver the STING agonist cyclic GMP-AMP (cGAMP) which achieved >10x dose-sparing
34 neered exosomes to deliver the STING agonist cyclic GMP-AMP (iExo(STINGa)), to exploit their favorabl
35 y a stimulator of IFN genes (STING) agonist, cyclic GMP-AMP (cGAMP), because together they synergize
38 CIN), leading to a tumor cell-autonomous and cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
39 and type III CRISPR systems in bacteria and cyclic GMP-AMP synthase-stimulator of interferon genes (
40 or 9 (TLR9) in the endosomal compartment and cyclic GMP-AMP synthase (cGAS) and absent in melanoma 2
41 Additionally, we determined that STING and cyclic GMP-AMP synthase (cGAS) are important to engage t
42 ryotic Toll/interleukin-1 receptor (TIR) and cyclic GMP-AMP synthase (cGAS) immunity, we discover sev
43 ng pathways, toll-like receptor 9 (TLR9) and cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
44 n immunity, targets of immunotherapy such as cyclic GMP-AMP synthase (cGAS) or PD-L1 can crosstalk wi
45 osolic nucleic acid sensor pathways, such as cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
46 future autoimmune therapies.Upon DNA binding cyclic GMP-AMP synthase (cGAS) produces a cyclic dinucle
47 is caused not by telomere shortening, but by cyclic GMP-AMP synthase (cGAS) recognizing cytosolic chr
49 robial infections and is quickly detected by cyclic GMP-AMP synthase (cGAS) to elicit anti-infection
53 increased interferon signaling, mediated by cyclic GMP-AMP synthase (cGAS) and stimulator of interfe
54 evel of mRNA upregulation to DAI/ZBP1, or by cyclic GMP-AMP synthase (cGAS), despite its presence in
55 clic GMP-AMP, a second messenger produced by cyclic GMP-AMP synthase (cGAS) as well as RNA ligands an
56 cluding cyclic GMP-AMP, which is produced by cyclic GMP-AMP synthase (cGAS) in response to cytosolic
57 adenosine monophosphate (cGAMP), produced by cyclic GMP-AMP synthase (cGAS), stimulates the productio
58 During infection, foreign DNA is sensed by cyclic GMP-AMP synthase (cGAS) leading to the production
59 n translates the sensing of cytosolic DNA by cyclic-GMP-AMP synthase (cGAS) into an inflammatory resp
62 e diffusible cyclic dinucleotide 2'3'-cGAMP (cyclic GMP-AMP), which subsequently binds to the adaptor
63 nzyme that catalyzes the synthesis of cGAMP (cyclic GMP-AMP), a critical second messenger along the r
65 fter detection of cytoplasmic dsDNA by cGAS (cyclic GMP-AMP synthase) as part of the innate immunity
66 sed DNA damage, and recruitment of the cGAS (cyclic GMP-AMP synthase) to the nuclear membrane and mic
70 of cytosolic DNA-sensing pathway comprising cyclic GMP-AMP (cGAMP) synthase (cGAS) and stimulator of
71 cal modulatory role for PARP9 in DNA damage, cyclic GMP-AMP synthase (cGAS) expression, and type I IF
72 terplay among the DNA damage response (DDR), cyclic GMP-AMP synthase-stimulator of interferon genes (
73 ses the synthesis of the cyclic dinucleotide cyclic GMP-AMP, which mediates the induction of type I i
75 are key in the pathogenesis of PD and drives cyclic GMP-AMP synthase (cGAS) and stimulator of interfe
77 during bacterial infection and in endogenous cyclic GMP-AMP signalling during viral infection and ant
80 w DNA-activated pathway involving the enzyme cyclic GMP-AMP synthase (cGAS) was described and potenti
83 been shown to bind cytosolic DNA to generate cyclic GMP-AMP, which binds to the signaling adaptor sti
87 y, we have compared the dependency on IFI16, cyclic GMP-AMP synthase, and stimulator of IFN genes for
88 ade since the discovery of the innate immune cyclic GMP-AMP synthase (cGAS)-2'3'-cyclic GMP-AMP (cGAM
89 lear transcription and via the innate immune cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
91 Several dinucleotide cyclases, including cyclic GMP-AMP synthase, and their involvement in STING-
92 s a sensor of cyclic dinucleotides including cyclic GMP-AMP, which is produced by cyclic GMP-AMP synt
93 e immune responses upon infection, including cyclic GMP-AMP synthase (cGAS) signaling that results in
96 chondrial DNA soiling of the cytosol induced cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
101 n to produce the nucleotide second messenger cyclic GMP-AMP (cGAMP), which initiates stimulator of in
104 signals by synthesis of a second messenger, cyclic GMP-AMP (cGAMP), which activates stimulator of in
105 ough the production of the second messenger, cyclic GMP-AMP (cGAMP), which binds and activates stimul
106 osine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP) in vitro from adenosine tripho
107 osine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP), which binds to and activates
110 ING pathway: this involves the activation of cyclic GMP-AMP (cGMP-AMP) synthase (cGAS) and generation
111 e immune responses through the activation of cyclic GMP-AMP synthase (cGAS) and production of the cyc
112 erferons and cytokines through activation of cyclic GMP-AMP synthase (cGAS) and stimulator of interfe
114 antigen cross-presentation and activation of cyclic GMP-AMP synthase-stimulator of interferon genes (
115 s active and selective in cellular assays of cyclic GMP-AMP synthase-mediated signaling and reduces c
116 Here, we report the discovery of a class of cyclic GMP-AMP synthase inhibitors identified by a high-
117 rferon genes (STING) functions downstream of cyclic GMP-AMP synthase in DNA sensing or as a direct re
118 studies have characterized ancient forms of cyclic GMP-AMP (cGAMP) synthase (cGAS)-like receptors (c
119 mical analyses showed enhanced generation of cyclic GMP-AMP, STING aggregation, and TANK-binding kina
120 a-associated herpesvirus (KSHV) inhibitor of cyclic GMP-AMP synthase (cGAS) (KicGAS) encoded by ORF52
121 have compromised expression or repression of cyclic GMP-AMP (cGAMP) synthase (cGAS), which prevents e
123 toward understanding the biological roles of cyclic GMP-AMP synthase and can serve as a molecular sca
124 onuclei formation and activates signaling of cyclic GMP-AMP synthase-stimulator of interferon genes (
125 onships and we present crystal structures of cyclic GMP-AMP synthase, double-stranded DNA, and inhibi
128 is activated and catalyzes the synthesis of cyclic GMP-AMP (cGAMP), which induces potent antimicrobi
129 ded DNA (dsDNA) to catalyze the synthesis of cyclic GMP-AMP (cGAMP), which serves as the secondary me
130 -cyclic dinucleotides (2'3'CDNs) with use of cyclic GMP-AMP synthases (cGAS) from human, mouse, and c
132 cyte-intrinsic responses to ERVs depended on cyclic GMP-AMP synthase (cGAS)/stimulator of interferon
134 animals, cGAS is activated by DNA to produce cyclic GMP-AMP (cGAMP)(4,5), which leads to the expressi
135 lso show expression of the antiviral protein cyclic GMP-AMP synthase (cGAS) in neuronal SH-SY5Y cells
136 ndent of the cytosolic nucleic acid receptor cyclic GMP-AMP (cGAMP) synthase (cGAS), but cGAS neverth
137 infection though the cytosolic DNA receptor cyclic GMP-AMP synthase (cGAS), which produces the secon
139 the cytoplasmic pattern recognition receptor cyclic GMP-AMP synthase (cGAS), thereby stimulating immu
140 y the cytosolic pattern recognition receptor cyclic GMP-AMP synthase (cGAS), which initiates a signal
143 y, particularly for the DNA-sensing receptor cyclic GMP-AMP synthase (cGAS) and its downstream signal
144 ell receptor and the innate immune receptors cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
146 atures of necroptosis; self-DNA recognition; cyclic GMP-AMP synthase/stimulator of IFN genes activati
147 acter sulfurreducens, specifically regulates cyclic GMP-AMP (3',3'-cGAMP) levels in vivo to stimulate
148 pase-11 in mice) and caspase-1, and requires cyclic GMP-AMP synthase (cGAS)-dependent interferon-beta
149 ed as a crucial regulator of the DNA-sensing cyclic GMP-AMP synthase (cGAS)-STING pathway, and this s
151 leotides that are produced by the DNA sensor cyclic GMP-AMP (cGAMP) synthase or by invading bacteria(
152 n of microbial DNA, the cytosolic DNA sensor cyclic GMP-AMP (cGAMP) synthetase (cGAS) produces the se
153 S2B protease cofactor targets the DNA sensor cyclic GMP-AMP synthase (cGAS) for lysosomal degradation
158 timulates the RNA sensor MDA5 and DNA sensor cyclic GMP-AMP synthase (cGAS) to boost type I interfero
159 tigated the roles of the putative DNA sensor cyclic GMP-AMP synthase (cGas), as well as the downstrea
160 ytosolic dsDNA, mainly by the key DNA sensor cyclic GMP-AMP synthase (cGAS), leads to the synthesis o
161 GMP-AMP (cGAMP), produced by the DNA sensor cyclic GMP-AMP synthase (cGAS), which is important for t
162 ustering highlights the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS, also known as MB21D1) as
163 rom activation of the cytoplasmic DNA sensor cyclic GMP-AMP synthase by a nucleic acid substrate of T
164 demonstrate that knocking out the DNA sensor cyclic GMP-AMP synthase completely abrogates spontaneous
165 ene (encoding an inhibitor of the DNA sensor cyclic GMP-AMP synthase, cGAS) and expression of two mem
166 nded DNA (dsDNA), the cytosolic dsDNA sensor cyclic GMP-AMP synthase (cGAS) synthesizes the diffusibl
167 upon the double-stranded DNA (dsDNA) sensor cyclic GMP-AMP synthase (cGAS), the innate immune adapto
168 rantly located DNA, the innate immune sensor cyclic GMP-AMP synthase (cGAS) activates stimulator of I
169 tructures activated the innate immune sensor cyclic GMP-AMP synthase (cGAS) and induced type I IFN pr
171 s a danger signal detected by the DNA sensor cyclic-GMP-AMP (cGAMP) synthase (cGAS), which catalyzes
173 recognized by the host cytosolic DNA sensor, cyclic GMP-AMP (cGAMP) synthase (cGAS), resulting in pro
174 data indicating that a cytosolic DNA sensor, cyclic GMP-AMP synthase (cGAS), is activated by DNA-indu
175 We report that the cytosolic DNA sensor, cyclic GMP-AMP synthase (cGAS), is required for activati
177 mechanism requiring the nucleic acid sensors cyclic GMP-AMP synthase (cGAS), stimulator of interferon
178 racellular sensors including the DNA sensors cyclic GMP-AMP (cGAMP) synthase (cGAS) and interferon ga
179 TBI increased expression of DNA sensors cyclic GMP-AMP synthase and stimulator of interferon gen
180 ecruited and activated 2 major DNA sensors - cyclic GMP-AMP synthase (cGAS) and absent in melanoma 2
181 y, we report that the cytosolic DNA sensors, cyclic GMP-AMP synthase (cGAS) and Ifi204, are both requ
182 e immunity cytosolic DNA-sensing cGAS-STING (cyclic GMP-AMP synthase linked to stimulator of interfer
183 r patterns that can activate the cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes)
184 n in innate immunity: the animal cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes)
185 chromatin fragments activate the cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes)
186 eins potently interfere with the cGAS-STING (cyclic GMP-AMP synthetase-stimulator of interferon genes
190 ral pathway, recent work has implicated that cyclic GMP-AMP-synthase-Stimulator of Interferon Genes (
203 ieres syndrome demonstrate that ablating the cyclic GMP-AMP synthase gene abolishes the deleterious p
204 enic and other cytoplasmic DNAs activate the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
205 that deletion of mutant Trp53 activated the cyclic GMP-AMP Synthase-Stimulator of Interferon Genes p
206 of extrachromosomal DNA, which activated the cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/ST
208 triggers immune responses by activating the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
209 ent an effective strategy for activating the cyclic GMP-AMP synthase-STING pathway in future clinical
210 st multiple sclerosis and psoriasis, and the cyclic GMP-AMP synthase/stimulator of interferon genes (
211 es simplex virus 1 (HSV-1) triggers both the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
213 into the host cell cytosol is sensed by the cyclic GMP-AMP synthase (cGAS) and stimulator of IFN gen
214 increased genomic instability, elevated the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon
215 ein 1 (PQBP1) as an adapter required for the cyclic GMP-AMP synthase (cGAS)-mediated innate response
216 context of promoting antitumor immunity, the cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/ST
217 c dinucleotides are second messengers in the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
218 unological DNA sensor proposed to act in the cyclic GMP-AMP synthase-stimulator of IFN genes pathway.
219 lammation are attenuated in mice lacking the cyclic GMP-AMP synthase (cGAS)-Stimulator of Interferon
220 ochondrial DNA (mtDNA) and activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
221 , recruitment of cGAS, and activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
222 s cytosolic DNA to prevent activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
223 sol, where it triggers the activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
224 events are associated with activation of the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon
225 ted with activation of the stimulator of the cyclic GMP-AMP synthase interferon genes (cGAS-STING) in
226 in part via inhibiting the activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (
227 caused largely by chronic activation of the cyclic GMP-AMP synthase-stimulator of interferon genes-T
228 high-throughput screen for inhibitors of the cyclic GMP-AMP synthase/stimulator of interferon genes p
229 of IFN genes (STING), a key component of the cyclic GMP-AMP synthase/STING pathway, is crucial for nu
230 N)beta production, which is dependent on the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon
231 d brain through a mechanism dependent on the cyclic GMP-AMP synthase/stimulator of interferon genes (
232 epigenetic silencing of either STING or the cyclic GMP-AMP synthase, which generates STING-activatin
233 th in immunocompetent mice by repressing the cyclic GMP-AMP synthase (cGAS)-dependent DNA sensing pat
234 sponse, in the present study, we studied the cyclic GMP-AMP synthase-stimulator of interferon genes (
235 ntle this sensing mechanism by targeting the cyclic GMP-AMP synthase (cGAS) and the stimulator of int
236 forms for the delivery of IIMs targeting the cyclic GMP-AMP synthase-stimulator of interferon genes p
237 ating the innate immune response through the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon
238 is thought to require signaling through the cyclic GMP-AMP synthase (cGAS)-STING pathway and subsequ
239 unction, and inflammatory cytokines, via the cyclic GMP-AMP synthase-STING and STAT3 signaling pathwa
240 diated dsRNA sensing in conjunction with the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon
241 cleus to prevent autoimmunity; despite this, cyclic GMP-AMP synthase (cGAS), a cytosolic sensor of do
242 terferons and inflammatory cytokines through cyclic GMP-AMP synthase, which produces 2'3'-cyclic GMP-
243 acid-inducible gene I (RIG-I) in response to cyclic GMP-AMP, a second messenger produced by cyclic GM
244 sponses to human CMV that are dependent upon cyclic GMP-AMP synthase (cGAS), STING, and interferon re
245 ere triggered by tumor-cell-derived DNA, via cyclic-GMP-AMP synthase (cGAS), STING, and interferon re